Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...
Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...
Barchart on MSN14h
Snag This Biotech Stock Before November, Here's WhyAs retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...
The Healthy on MSN13h
“Here’s What Happened When I Stopped Taking Ozempic”: One Patient’s Story Navigating a New NormalDid she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who ...
According to Tom Lee, Co-founder and Managing Partner at Fundstrat Global Advisors, this is the type of performance investors can expect to see over the next eight weeks up to Election Day – and ...
First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, ...
• Oakland County Water Resources Commissioner Jim Nash will share information about invasive species and the RainSmart ...
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback